TIM-3 and TIGIT are possible immune checkpoint targets in patients with bladder cancer
Kyrollis Attalla, Adam M. Farkas, Harry Anastos, François Audenet, Matthew D. Galsky, Nina Bhardwaj, John P. Sfakianos
Topics & Concepts
TIGITImmune systemImmune checkpointCytotoxic T cellImmunotherapyT cellCancer immunotherapyAntibodyCancer researchImmunologyBiologyAntigenGeneticsIn vitroGalectins and Cancer BiologyImmune Cell Function and InteractionCancer Immunotherapy and Biomarkers